Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine and Full Agonist Opioids for Cancer Pain
NCT05910190Phase 4Unknown
- Sponsor
- Fox Chase Cancer Center
- Start
- Aug 2022
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine in cancer-related pain, sponsored by Fox Chase Cancer Center. Status: unknown.
02
Drugs
buprenorphine
03
Conditions
cancer-related pain
Beyond the preview
Go deeper on NCT05910190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05910190.